Shanghai Medicilon (SHSE:688202) FCF Margin %: -12.98% (As of Mar. 2026)

What is Shanghai Medicilon FCF Margin %?

Shanghai Medicilon SHSE:688202 -1.29% 73 FCF Margin % is -12.98% as of Mar. 2026. GuruFocus rates SHSE:688202 with a GF Score™ of 73/100 and a GF Value™ of ¥46.13 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 958 Biotechnology companies, Shanghai Medicilon ranks better than 75.05% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Shanghai Medicilon's Free Cash Flow for the three months ended in Mar. 2026 was ¥-47 Mil. Shanghai Medicilon's Revenue for the three months ended in Mar. 2026 was ¥365 Mil. Therefore, Shanghai Medicilon's FCF Margin % for the quarter that ended in Mar. 2026 was -12.98%.

As of today, Shanghai Medicilon's current FCF Yield % is 0.07%.

The historical rank and industry rank for Shanghai Medicilon's FCF Margin % or its related term are showing as below:

SHSE:688202' s FCF Margin % Range Over the Past 10 Years
Min: -25.64 Med: -0.08 Max: 13.73
Current: 0.49

During the past 12 years, the highest FCF Margin % of Shanghai Medicilon was 13.73%. The lowest was -25.64%. And the median was -0.08%.

SHSE:688202's FCF Margin % is ranked better than
75.05% of 958 companies
in the Biotechnology industry
Industry Median: -85.21 vs SHSE:688202: 0.49

Shanghai Medicilon FCF Margin % Related Terms

Shanghai Medicilon FCF Margin % Historical Data

* Premium members only.

The historical data trend for Shanghai Medicilon's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Medicilon FCF Margin % Chart

Shanghai Medicilon Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

13.73

-25.64

-11.16

-12.83

3.11

Shanghai Medicilon Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															-6.49	22.85	-17.28	13.53	-12.98

SHSE:688202 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Shanghai Medicilon's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Medicilon FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Medicilon's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Shanghai Medicilon's FCF Margin % falls into.

Save Embed

73GF Score

Shanghai Medicilon Inc SHSE:688202

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Shanghai Medicilon FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Shanghai Medicilon's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	36.14	/	1163.062
	=	3.11 %

Shanghai Medicilon's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-47.315	/	364.644
	=	-12.98 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -12.98% mean?

Shanghai Medicilon (SHSE:688202) has a FCF Margin % of -12.98% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Medicilon and its competitors. According to the industry distribution chart, Shanghai Medicilon ranks #239 out of 958 companies in the Biotechnology industry, placing it in the top 24.9%.

Is Shanghai Medicilon's FCF Margin % too high?

Shanghai Medicilon's current FCF Margin % is -12.98%. Based on the distribution chart, Shanghai Medicilon ranks #239 out of 958 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Medicilon has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Shanghai Medicilon's FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Shanghai Medicilon ranks #239 out of 958 companies for FCF Margin %. This places Shanghai Medicilon in the top 25% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shanghai Medicilon and its competitors. Shanghai Medicilon's current FCF Margin % is -12.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shanghai Medicilon stock overvalued right now?

Based on GuruFocus' analysis, Shanghai Medicilon (SHSE:688202) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥46.13, compared to a current price of ¥70.57 — trading 53% above its estimated fair value. The current FCF Margin % is -12.98%. Shanghai Medicilon's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Shanghai Medicilon (SHSE:688202), the current FCF Margin % is -12.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Medicilon (SHSE:688202) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Medicilon stock appears to be overvalued. The current stock price of ¥70.57 is trading 53% above its estimated GF Value™ of ¥46.13. GuruFocus considers Shanghai Medicilon to be Significantly Overvalued.

Key valuation signals for SHSE:688202:

FCF Margin %: -12.98%
GF Value™: ¥46.13 vs. price of ¥70.57 (53% above fair value)
GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the SHSE:688202 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Medicilon Business Description

Industry Healthcare Biotechnology

Comparable Companies SHSE:688068 SHSE:605116 SHSE:688177 SHSE:688658 SHSE:688253 SHSE:603229 SHSE:688046 SZSE:301047 SZSE:300497 SHSE:688105 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Address Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299

Website http://www.medicilon.com.cn

Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.

73GF Score

Get the complete analysis for SHSE:688202

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥70.57

Price

¥46.13

GF Value

View SHSE:688202 Analysis

See FCF Margin % data for all stocks →